Tagged with Research,

Luxembourg Luxembourg is steadily increasing its social security coverage to include a broader percentage of its population. Luxembourg has one of the highest health expenditures per capita in the world; second only to the USA. A whopping 44.5% of those working in Luxembourg are non-nationals; a percentage way ahead of anywhere else…

Taiwan Kao Su-Chin Chang, founder and chairman of Weidar Chemical and Pharmaceutical, describes the robust development and international expansion of this historical domestic pharmaceutical manufacturer and the company’s enduring commitment to maintaining the excellence of its manufacturing capacity, which has allowed Weidar to establish itself as one of the foremost generics…

Singapore The Asia-Pacific region is a vast geographic area, home to almost half of the world’s population and numerous emerging and developed markets with great investment potential for healthcare and life sciences companies. However, the degree of diversity within Asia-Pacific creates formidable challenges for MNCs operating in the region. “APAC is…

Ireland Patsy Carney, co-founder and CEO of EirGen Pharma, tells us the strategy behind their 2015 acquisition by US-based OPKO Health, the highlights of their current transformation from an Irish CDMO business to a center of excellence in R&D and supply chain for the Group, the new sterile, oral solid dose…

Taiwan Grace Yeh, Founder, President, and CEO of PharmaEngine, one of the most eye-catching success stories to recently emerge from Taiwan’s maturing biopharmaceutical sector, documents the main success factors that have allowed PharmaEngine to become the first Taiwan-based company to receive FDA approval for a locally-developed oncology treatment, as well as…

Singapore In an exclusive interview with Alan Ong, Executive Vice President of Asia Pacific and Global Head of Medical Devices and Diagnostics at INC Research, he highlights the current trends facing CROs in the region and the increasing capabilities and footprint of INC Research in Singapore. As the Executive Vice President…

Ireland Darren Cunningham tells us the story behind Inflection Biosciences (and its name), the rationale of focusing on small molecule cancer treatments, his thoughts on the Irish biotech start-up scene, and his hopes for the company’s future development. Can you first provide an introduction to Inflection Biosciences to our international audience? “The Irish…

Luxembourg The CEO of LIH, Dr Catherine Larue, reveals how LIH’s mission is to translate research knowledge into clinical applications; how since 2008, Luxembourg has made personalized healthcare a priority area, particularly for cancer patients; and why Luxembourg has all the ingredients to be considered amongst the leading life sciences countries…

Luxembourg Marc Schiltz reveals the ambitions of Luxembourg’s National Research Fund (FNR), how his team are encouraging integration and doing far more than just delivering funds to willing researchers. Over the past 5 years, you have taken it upon yourself to internally reorganize the Luxembourg National Research Fund ( FNR), sharpen…

Singapore Biotech CRO InvitroCue Executive director Dr. Steven Fang explains how their technology has disrupted the current clinical trials landscape and the importance of leveraging innovative technologies in meeting future healthcare needs. Could you please introduce to our international readers the main activities of InvitroCue as well as the milestones since…

Luxembourg The CEO of Mitotech introduces the ground-breaking nature of their products; why Mitotech chose Luxembourg to set up its headquarters, as well as the commercial and internalization strategies they will be implementing moving forward. Could you please start by introducing Mitotech to our audience? “Luxembourg has been efficient in communicating…

Luxembourg The General Manager EMEA of Wafergen Biosystems discusses the revolutionary nature of the company’s technologies, how they are at the new frontier of genomic research, why Wafergen set up its EMEA office in Luxembourg,  growth hotspots in the EMEA region, and the recent merger with Japanese group Takara Bio. To…